[Federal Register Volume 64, Number 165 (Thursday, August 26, 1999)]
[Notices]
[Pages 46686-46687]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22151]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 98D-0362]


Advisory Committee for Pharmaceutical Science Site-Specific 
Stability Subcommittee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Advisory Committee for Pharmaceutical Science 
Site-Specific Stability Subcommittee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on September 22, 1999, 8:30 
a.m. to 5 p.m.
    Location: Center for Drug Evaluation and Research Advisory 
Committee Conference Room, 5630 Fishers Lane, Rockville, MD.
    Contact Person: Kimberly Littleton Topper at T[email protected] 
or Angie Whitacre at W[email protected], Center for Drug Evaluation 
and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane 
Rockville, MD 20857, (301) 827-7001, or FDA Advisory Committee

[[Page 46687]]

Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12539. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The subcommittee will discuss the March site-specific 
stability proposal from the agency and the public comments submitted to 
Docket No. 98D-0362.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by September 8, 
1999. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before September 8, 1999, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: August 18, 1999.
 Linda A. Suydam,
 Senior Associate Commissioner.
[FR Doc. 99-22151 Filed 8-25-99; 8:45 am]
BILLING CODE 4160-01-F